Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

 v2.3.0.11
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
REVENUE:        
PCT Products, services, other $ 190,686 $ 283,382 $ 371,329 $ 472,532
Grant revenue 0 118,722 0 220,385
Total revenue 190,686 402,104 371,329 692,917
COSTS AND EXPENSES:        
Cost of PCT products and services 78,296 126,972 157,225 214,075
Research and development 263,809 304,143 482,774 598,284
Selling and marketing 242,544 294,275 546,383 576,853
General and administrative 448,314 474,381 860,843 1,012,803
Total operating costs and expenses 1,032,963 1,199,771 2,047,225 2,402,015
Operating loss (842,277) (797,667) (1,675,896) (1,709,098)
Interest income 75 1,016 329 1,122
Warrant income relating to revaluation 84,021 0 84,021 0
Net loss (758,181) (796,651) (1,591,546) (1,707,976)
Accrued and deemed dividends on convertible preferred stock (414,360) (127,839) (547,451) (384,363)
Net loss applicable to common shareholders $ (1,172,541) $ (924,490) $ (2,138,997) $ (2,092,339)
Net loss per share attributable to common stockholders - basic and diluted (in dollars per share) $ (0.41) $ (0.35) $ (0.75) $ (0.80)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation (in shares) 2,874,305 2,621,291 2,867,381 2,615,557